Caleres, Inc. engages in the designs, develops, sources, manufactures, and distributes footwear in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, Adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr. Martens, Reef, Asics, Bearpaw, HeyDude, and Veronica Beard brands, as well as company-owned and licensed brands, such as Sam Edelman, Vionic, Allen Edmonds, Franco Sarto, Rykä, Vince, Favorite Daughter, LifeStride, Dr. Scholl's Shoes, Blowfish Malibu, and Naturalizer. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, samedelman.co.uk, allenedmonds.com, allenedmonds.ca, shoebank.com, drschollsshoes.com, lifestride.com, francosarto.com, and ryka.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as online retailers, national chains, department stores, mass merchandisers, and independent retailers. Further, the company wholesales men's footwear, apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear collection under Veronica Beard brand. The company operates through retail shoe stores, wholesales, and e-commerce websites. The company was formerly known as Brown Shoe Company, Inc. and changed its name to Caleres, Inc. in May 2015. Caleres, Inc. was founded in 1878 and is headquartered in Saint Louis, Missouri.

Caleres, Inc.

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Camden Property, with a price target of $108.00. Accordi...

Truist Financial Keeps Their Buy Rating on Camden Property (CPT)

Polynovo ( ($AU:PNV) ) just unveiled an announcement. PolyNovo has strengthened its board with the appointment of medical technology veterans Dean ...

PolyNovo refreshes board with new non-executive directors to drive global growth

CalciMedica ( ($CALC) ) has shared an update. On March 16, 2026, CalciMedica received a notice from Nasdaq that its common stock had traded below t...

CalciMedica Regains Nasdaq Compliance, Listing Status Stabilized

UBS analyst Ami Probandt maintained a Hold rating on Camden Property today and set a price target of $105.00. According to TipRanks, Probandt is an...

UBS Sticks to Their Hold Rating for Camden Property (CPT)

Polynovo ( ($AU:PNV) ) has issued an update. PolyNovo has lodged its corporate governance statement for the financial year ended 30 June 2026, conf...

PolyNovo files updated corporate governance statement and Appendix 4G

CALIDA Holding AG ( ($CH:CALN) ) has provided an update. Calida Group faces a first-instance ruling from the Tribunal de Commerce de Paris that par...

Calida Hit with EUR 6.4 Million Lafuma Damages but Reaffirms Profit Targets

Caleres Inc (CAL) has disclosed a new risk, in the Regulation category. Caleres Inc faces heightened uncertainty because its disclosures may contai...

Caleres Inc Warns Investors: Forward-Looking Statements Pose Significant Performance Risk

Caleres Inc (($CAL)) has held its Q2 earnings call. Read on for the main highlights of the call. Caleres’ latest earnings call struck a notably upb...

Caleres Earnings Call Highlights Brand Strength, Famous Woes

An update from CalciMedica ( ($CALC) ) is now available. On August 31, 2026, CalciMedica reported that Nasdaq staff determined the company now sati...

CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk

Dishman Carbogen Amcis Ltd. ( ($IN:DCAL) ) just unveiled an update. Dishman Carbogen Amcis Limited has announced a change in senior management, dis...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CAL	$12.52	+0.24%	366.05K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CAL	$12.52	+0.2%	366.05K
3
4
5
6

CAL

Get Caleres, Inc. Data in Excel

Get Caleres, Inc. Data in Excel